Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Placenta|July 1, 1988
The appearance of transferrin receptors on cultured human cytotrophoblast and in vitro-formed syncytiotrophoblastM B Bierings, H J Adriaansen, J P Van Dijk
Journal of Developmental Physiology|July 1, 1990
An investigation of placental transferrin processing: influence of N-ethylmaleimideJ P van Dijk, M B Bierings, F G van der Zande
Molecular and Cellular Biochemistry|January 16, 1991
Transferrin receptor expression and the regulation of placental iron uptakeM B Bierings, M R Baert, H G van Eijk, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1987
Pregnancy and guinea-pig isotransferrins--isolation and characterization of both isotransferrinsM B Bierings, J W Heeren, W L van Noort, et al.
Leukemia|August 5, 2006
Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic reviewC M van Tilburg, E A M Sanders, M M Rovers, et al.
Bone Marrow Transplantation|August 24, 2011
Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology GroupM M Jöris, M B Bierings, R M Egeler, et al.
Quality & Safety in Health Care|February 4, 2006
Health Care Failure Mode and Effect Analysis: a useful proactive risk analysis in a pediatric oncology wardC M van Tilburg, I P Leistikow, C M A Rademaker, et al.
Bone Marrow Transplantation|July 29, 2014
Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: results from a prospective, multicenter registryJ P J van Gestel, M B Bierings, S Dauger, et al.
Bone Marrow Transplantation|October 15, 2013
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipientsJ A Hol, T F W Wolfs, M B Bierings, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicityI H Bartelink, E M L van Reij, C E Gerhardt, et al.
Pageof 2